Ya hay una droga oral para la depresión postparto… pero cuesta $16,000
En diciembre se lanzó al mercado zuranolona, un tratamiento muy esperado para la depresión postparto, con…
Read More...
Read More...
GOP-Led States Increase Crackdowns on Transgender Care
South Carolina’s legislature is poised to pass a bill prohibiting doctors from offering some health-care…
Read More...
Read More...
Secret Contract Goals to Upend Landmark California Jail Litigation
SACRAMENTO, Calif. — California commissioned an exhaustive study of whether its prisons are providing…
Read More...
Read More...
West Virginia Metropolis As soon as Battered by Opioid Overdoses Confronts ‘Fourth Wave’
HUNTINGTON, W.Va. — From 2006 through 2014, more than 81 million painkiller pills were shipped to this city…
Read More...
Read More...
Issues Develop Over High quality of Care as Investor Teams Purchase Not-for-Revenue Nursing…
Shelly Olson’s mother, who has dementia, has lived at the Scandia Village nursing home in rural Sister Bay,…
Read More...
Read More...
Constructing Meta’s GenAI Infrastructure – Engineering at Meta
Marking a major investment in Meta’s AI future, we are announcing two 24k GPU clusters. We are sharing details on…
Read More...
Read More...
California Voters Are Skeptical That Extra Cash Is the Reply to Homelessness
SACRAMENTO, Calif. — California Gov. Gavin Newsom’s expensive ballot-box attempt to tackle the mental…
Read More...
Read More...
How the Anti-Vaccine Motion Pits Parental Rights In opposition to Public Well being
Gayle Borne has fostered more than 300 children in Springfield, Tennessee. She’s cared for kids who have…
Read More...
Read More...
A New $16,000 Postpartum Despair Drug Is Right here. How Will Insurers Deal with It?
April Dembosky, KQED
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December,…
Read More...
Read More...
Colorado Isn’t Giving up on Its Drug Importation Dream
Colorado hopes to join Florida to become only the second state authorized to import prescription drugs from…
Read More...
Read More...